14 departments jointly crack down on unhealthy practices in pharmaceutical procurement and sales and medical services
The cleanup of pharmaceutical procurement and sales focuses on corruption and chaos, promoting standardized governance of medical services Strengthen coordinated law enforcement and long-term supervision to safeguard the medical insurance fund and the health rights and interests of the public
The National Health Commission and 13 other departments recently jointly issued the "2026 Work Plan for Correcting Malpractice in Pharmaceutical Purchasing and Sales and Medical Services," making it clear that they will continue to deepen the centralized rectification of corruption and misconduct in the pharmaceutical sector, promote standardized industry governance, and safeguard the public's health rights and interests.
The work plan focuses on multiple areas, including Partybuilding guidance, the development of medical ethics and professional conduct, risk prevention and control, medical data security, the regulation of purchasing and sales order, and the safety of medical insurance funds. It will重点 address issues such as the procurement of drugs and consumables, the transfer of利益 through academic activities, illegal practice, issuing false invoices, and the improper use of medical insurance funds.
The document also proposes strengthening crossdepartmental law enforcement coordination to curb industry disorder in fields such as medical aesthetics, surrogacy, false birth certificates, and illegal medical practice. It also aims to improve the governance level of the healthcare industry by完善 longterm mechanisms, strengthening supervision, and enhancing information disclosure.